|
Compound Information
|
| ID |
112 |
| TrivialName |
Gypenoside CXIV |
| Type |
PPD |
| MF |
C₄₈H₈₂O₂₀ |
| MolecularWeight |
979.164 |
| IUPACName |
NT |
| m/z |
NT |
| Retention Time |
NT |
| CCS |
NT |
| Adducts |
NT |
| Isomeric SMILES |
C[C@@]12C(CC[C@]3(C)C2C[C@@H](O)C4[C@@]3(C)CC[C@@H]4[C@@](CCC(O)C(C)=C)(C)O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O5)C(C)(C)[C@@H](O[C@H]6[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O)C1 |
| Canonical SMILES |
C=C(C)C(O)CCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CC(O)C(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
| Source |
Other |
| Functions |
alleviates neuroinflammation and blood brain barrier |
| Year |
2021 |
| References |
Lou et al. (2021)
|
| Structure |
|
